DataKnowledgeCloudtrainingcoordination

NPC.215 (Subject)

Taxonomy Id:

Homo sapiens

Taxonomy (Entity type)

Role Id:

cell line ancestor

Subject Role (Entity type)

Project:

LINCS

Project (Entity type)

Granularity:

cell line

Subject Granularity (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H B15 olanzapine 6.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC CEGS001 NPC.215 24H N15 roflumilast 2.5uM.tsv.gz File (Entity type)	A 167 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H I01 BRD-K89997465 25uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H K17 tretinoin 1.67uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H B24 BRD-A90543464 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H L05 clozapine 1.67uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H E11 fluvastatin 1.67uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H F08 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H N17 roflumilast 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H M24 zopiclone 0.74uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H B15 olanzapine 6.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC CEGS001 NPC.215 24H N15 roflumilast 2.5uM.tsv.gz

File (Entity type)

A 167 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H I01 BRD-K89997465 25uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H K17 tretinoin 1.67uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H B24 BRD-A90543464 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H L05 clozapine 1.67uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H E11 fluvastatin 1.67uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H F08 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H N17 roflumilast 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CEGS001 NPC.215 24H M24 zopiclone 0.74uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.